Cancer Research UK logo.
SearchDonate
  • Search

A trial of a drug called methylphenidate for people with tiredness caused by cancer (MePFAC)

Overview

Cancer types:

All cancer types, Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is for people who have moderate or severe tiredness (fatigue) caused by advanced cancer.

Advanced cancer means that the cancer has spread from where it started to another part of the body. It is for people with any type of cancer that cannot be cured.

Recruitment start: 29 June 2018

Recruitment end: 28 April 2023

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor P Stone

Supported by

Priment Clinical Trial Unit

National Institute for Health Research (NIHR)

NIHR Health Technology Assessment (HTA) programme

University College London (UCL)

Marie Curie Cancer Care

Last reviewed: 27 April 2023

CRUK internal database number: 15240

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.